Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmace… Read more
Epsilon Healthcare Limited (HDRPF) - Total Assets
Latest total assets as of December 2024: $22.26 Million USD
Based on the latest financial reports, Epsilon Healthcare Limited (HDRPF) holds total assets worth $22.26 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Epsilon Healthcare Limited - Total Assets Trend (2016–2024)
This chart illustrates how Epsilon Healthcare Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Epsilon Healthcare Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Epsilon Healthcare Limited's total assets of $22.26 Million consist of 16.6% current assets and 83.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.4% |
| Accounts Receivable | $675.54K | 3.0% |
| Inventory | $528.99K | 2.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Epsilon Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Epsilon Healthcare Limited's current assets represent 16.6% of total assets in 2024, a decrease from 41.0% in 2016.
- Cash Position: Cash and equivalents constituted 4.4% of total assets in 2024, down from 31.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 58.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 3.0% of total assets.
Epsilon Healthcare Limited Competitors by Total Assets
Key competitors of Epsilon Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Epsilon Healthcare Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Epsilon Healthcare Limited generates 0.25x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Epsilon Healthcare Limited is currently not profitable relative to its asset base.
Epsilon Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.52 | 0.33 | 6.85 |
| Quick Ratio | 0.44 | 0.33 | 5.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.43 Million | $ -4.27 Million | $ 5.24 Million |
Epsilon Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Epsilon Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.13 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 54.5% |
| Total Assets | $22.26 Million |
| Market Capitalization | $338.96K USD |
Valuation Analysis
Below Book Valuation: The market values Epsilon Healthcare Limited's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Epsilon Healthcare Limited's assets grew by 54.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Epsilon Healthcare Limited (2016–2024)
The table below shows the annual total assets of Epsilon Healthcare Limited from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $22.26 Million | +54.46% |
| 2023-12-31 | $14.41 Million | -29.70% |
| 2022-12-31 | $20.50 Million | -32.90% |
| 2021-12-31 | $30.55 Million | -18.01% |
| 2020-12-31 | $37.26 Million | +33.97% |
| 2019-12-31 | $27.81 Million | -15.06% |
| 2018-12-31 | $32.75 Million | +49.21% |
| 2017-12-31 | $21.95 Million | +91.50% |
| 2016-12-31 | $11.46 Million | -- |